ksi-301
Showing 1 - 7 of 7
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
- KSI-301
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)
Active, not recruiting
- Non-proliferative Diabetic Retinopathy
- KSI-301
- Sham injection
-
Phoenix, Arizona
- +46 more
Sep 22, 2022
Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Diabetic Macular Edema
- KSI-301
- +2 more
-
Bakersfield, California
- +45 more
Jun 2, 2022
Wet Age-related Macular Degeneration Trial in Puerto Rico, United States (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Wet Age-related Macular Degeneration
- KSI-301
- +2 more
-
Phoenix, Arizona
- +65 more
Jun 2, 2022
Wet Macular Degeneration Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Terminated
- Wet Macular Degeneration
- KSI-301
- +2 more
-
Phoenix, Arizona
- +74 more
Jun 2, 2022
Diabetic Macular Edema Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Diabetic Macular Edema
- KSI-301
- +2 more
-
Phoenix, Arizona
- +87 more
Jun 2, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022